亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Safety of AG200-15, an Investigational Transdermal Patch, in Three Phase 3 Studies [1J]

医学 不利影响 中止 恶心 内科学
作者
Anita L. Nelson,Andrew M. Kaunitz,Robin Kroll,James A. Simon,Paula M. Castaño,Elizabeth Garner
出处
期刊:Obstetrics & Gynecology [Lippincott Williams & Wilkins]
卷期号:133 (1): 107S-107S
标识
DOI:10.1097/01.aog.0000558820.55364.92
摘要

INTRODUCTION: AG200-15 (Twirla®) is an investigational transdermal contraceptive delivery system (TCDS), which delivers daily exposure of approximately 120 µg of levonorgestrel and 30Î1/4 g of ethinyl estradiol. We report the safety from three Phase 3 studies - the SECURE (ATI-CL23) study, ATI-CL12, and ATI-CL-13. METHODS: SECURE was a single-arm, 13-cycle, open-label study conducted in 2014-2016. ATI-CL12 (13-cycles) and ATI-CL13 (6-cycles) were conducted in 2010-2011 and were open-label, randomized, active-controlled (an approved oral contraceptive (OC)) safety and efficacy studies. Subjects reported all treatment emergent adverse events (TEAEs) and serious adverse events (SAEs). TEAEs were defined as adverse events with an onset date on or after the first patch application through Day 28 of the subject's final treatment cycle. The results reported represent combined safety data. RESULTS: For AG200-15 in all studies combined, 54% of 3,481 subjects had at least one TEAE, 26% had at least one study drug-related TEAE, 5% had TEAEs of severe intensity, and 11% had TEAEs resulting in study drug discontinuation. Fewer than 2 percent of subjects (n=56) had SAEs, and 0.5% (n=18) had study drug-related SAEs. The SAEs occurring in >2 subjects were cholelithiasis (n=4), deep vein thrombosis (3), pulmonary embolism (3), and depression (3). No deaths were reported. The most common TEAEs (≥-2%) included nasopharyngitis (5.7%), upper respiratory tract infection (4.5%), nausea (4.3%), headache (3.6%), and urinary tract infections (3.5%). CONCLUSION: The percentages of TEAEs and SAEs were generally similar across the Phase 3 studies. The adverse event profile of AG200-15 appears to be similar to approved OCs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
MchemG应助科研通管家采纳,获得10
11秒前
闫雪完成签到,获得积分10
14秒前
16秒前
闫雪发布了新的文献求助10
21秒前
Plum22发布了新的文献求助20
32秒前
直觉应助闫雪采纳,获得10
32秒前
蚂蚁踢大象完成签到 ,获得积分10
1分钟前
hgsgeospan完成签到,获得积分10
1分钟前
直率的笑翠完成签到 ,获得积分10
1分钟前
hgs完成签到,获得积分10
1分钟前
1分钟前
MchemG应助科研通管家采纳,获得10
2分钟前
JamesPei应助科研通管家采纳,获得10
2分钟前
隐形曼青应助科研通管家采纳,获得10
2分钟前
Kevin完成签到,获得积分10
2分钟前
2分钟前
辉哥发布了新的文献求助10
2分钟前
3分钟前
3分钟前
董可以发布了新的文献求助10
3分钟前
英俊的铭应助董可以采纳,获得10
3分钟前
curtain完成签到,获得积分10
3分钟前
大个应助科研通管家采纳,获得10
4分钟前
MchemG应助科研通管家采纳,获得10
4分钟前
所所应助科研通管家采纳,获得10
4分钟前
科研通AI2S应助科研通管家采纳,获得10
4分钟前
4分钟前
落寞书易完成签到 ,获得积分10
4分钟前
4分钟前
现实的小霸王完成签到,获得积分10
4分钟前
4分钟前
Xw完成签到,获得积分10
5分钟前
科研通AI5应助迷人问兰采纳,获得10
5分钟前
Hello应助LSH970829采纳,获得10
5分钟前
Xw发布了新的文献求助10
5分钟前
寒冷的应助核桃采纳,获得30
5分钟前
wen发布了新的文献求助10
6分钟前
隐形曼青应助科研通管家采纳,获得10
6分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
MchemG应助科研通管家采纳,获得10
6分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990084
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256447
捐赠科研通 3271016
什么是DOI,文献DOI怎么找? 1805171
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228